Warfarin
467 results
301 - 400
lovastatin- norfloxacin
- sparfloxacin
- losartan
- vemurafenib
- ivacaftor
- atorvastatin/ezetimibe
- tezacaftor/ivacaftor
- acetoHEXAMIDE
- rosuvastatin
- St. John's wort
- topiramate
- ofloxacin
- simvastatin
- fluvoxaMINE
- sertraline
- bosentan
- clopidogrel
- droNABinol
- heparin
- omeprazole
- dexAMETHasone
- atorvastatin
- gatifloxacin
- obeticholic acid
- ivermectin
- sofosbuvir
- fosaprepitant
- aprepitant
- torsemide
Atrial Fibrillation- Vertebrobasilar Insufficiency
- Pulmonary Embolism
- Defibrillators, Implantable
- Transient Ischemic Attack (TIA)
- tenecteplase
- tinzaparin
- ibuprofen
- ceritinib
- elexacaftor/tezacaftor/ivacaftor
- bicalutamide
- bivalirudin
- esomeprazole
- methotrexate
- quiNINE
- sildenafil
- Atrial Flutter
- FLUoxetine
- gemifloxacin
- aspirin
- trimethoprim/sulfamethoxazole
- Cardiomyopathy, Peripartum
- streptokinase
- anistreplase
- oritavancin
- lumacaftor/ivacaftor
- asciminib
- ascorbic acid
- bretylium
- METHYLPHENIDATE
- nevirapine
- QUINIDINE
- VALPROATES
SITUATIONS IN WHICH DRUG MONITORING MAY NOT BE USEFUL- cephapirin
- butalbital, aspirin, and caffeine†
- levothyroxine
- daclatasvir
- elbasvir/grazoprevir
- ERYTHROMYCIN
- gefitinib
- imatinib
- lansoprazole
- Coagulopathy Reversal (Nonwarfarin Agents)
- regorafenib
- amivantamab
- levocarnitine
- delavirdine
- fenofibrate
- morphine
- erlotinib
- capecitabine
- GENETIC INFLUENCES ON THERAPEUTIC DRUG RESPONSE
- dexlansoprazole
- vilazodone
- teriflunomide
- levomilnacipran
- glecaprevir/pibrentasvir
- buPROPion
- carBAMazepine
- fluconazole
- mirtazapine
- ciprofloxacin
- Russell viper venom time (dRVVT)
- desvenlafaxine